301201 诚达药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.334-0.563-1.2724.0517.762
总资产报酬率 ROA (%)0.299-0.498-1.1493.8097.087
投入资产回报率 ROIC (%)0.321-0.538-1.2294.0047.529

边际利润分析
销售毛利率 (%)33.13244.17142.82142.88648.009
营业利润率 (%)7.651-1.927-7.37526.01930.196
息税前利润/营业总收入 (%)8.801-3.023-9.37223.29927.876
净利润/营业总收入 (%)5.476-2.943-8.29721.98925.878

收益指标分析
经营活动净收益/利润总额(%)51.392-37.324220.51260.24871.297
价值变动净收益/利润总额(%)31.932-114.545-119.15640.11933.021
营业外收支净额/利润总额(%)-4.81440.9629.614-3.404-3.445

偿债能力分析
流动比率 (X)7.5746.4266.8449.57816.876
速动比率 (X)6.7195.6956.1908.81715.305
资产负债率 (%)9.78210.75911.9347.1854.557
带息债务/全部投入资本 (%)2.9613.6134.6081.7320.077
股东权益/带息债务 (%)3,258.8372,661.0272,066.1775,660.638129,661.467
股东权益/负债合计 (%)921.176828.393737.0351,290.8642,092.776
利息保障倍数 (X)5.860-12.5517.730-12.503-21.210

营运能力分析
应收账款周转天数 (天)84.39489.655118.494100.94086.132
存货周转天数 (天)154.956225.090251.118218.244219.281